Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
Article L233-8-II of the French Commercial Code Article 223-16 of the General Regulations of the AMF (French Financial Markets Authority...
Consolidated sales of €2.4m at end June 2024 Cash position of €5.3m before IRIS Pharma CIR (€610k) at June 30, 2024 Regulatory News: ABIONYX...
Regulatory News: ABIONYX Pharma (Paris:ABNX): Place de cotation : Euronext Paris, Compartiment C Code ISIN : FR0012616852 Date Nombre de titres...
Regulatory News: Au titre du contrat de liquidité confié par la société ABIONYX Pharma (Paris:ABNX) à la Société TP ICAP (Europe) SA, à la date...
c.€3.4 million by issuing shares with warrants Subscription price: €1.37 for one share with warrants 1 warrant gives entitlement to 1 share to...
Regulatory News: ABIONYX Pharma, (FR0012616852 – ABNX – éligible PEA PME), société de biotechnologie de nouvelle génération dédiée à la...
Montant d’environ 3,4 millions d'euros par émission d’actions assorties de bons de souscription d’actions (« ABSA ») Prix de souscription : 1,37...
Based on encouraging Phase 2a data and a productive pre-IND Type B meeting with U.S. Food and Drug Administration (FDA), ABIONYX Pharma intends...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관